Last updates:

A. Steering EU public health

•  State of health in the EU
  • Ensuring the sustainability of Europe’s health systems
  • Driving patient-oriented innovations in EU health systems
  • Economic crisis and healthcare: European health strategy
•  Health programmes
  • ​EU4Health Programme (2021-2027)

Enter

B. Ensuring health security

•  Preparedness and response
  • Combating serious cross-border threats to health
    
  • EU digital COVID certificate
•  Blood, tissues and organs
  • Quality and safety of organs intended for transplantation
  • Quality standards to be met by blood banks
  • Safe human tissues & cells for transplantation
  • Human blood and blood components - maintaining standards​

C. Improving healthcare systems

 

• Cross-border healthcare
  • Healthcare in other EU countries — patients’ rights
  • European health insurance card
•  Healthcare workforce
  • The EU’s healthcare workforce
  • Preventing injuries to healthcare workers: EU social partners' agreement
•  Patient safety
  • Patient safety and the prevention of healthcare associated infections
  • Patient safety and quality of care in EU public health systems
•  eHealth
  • Unlocking the potential for mHealth (mobile health) in the EU

D. Risk assessment

​

• The precautionary principle

•  Scientific committees
  • EU scientific committees on consumer safety (SCCS) & on health, environmental and emerging risks (SCHEER)

E. Disease prevention

 ​

• Antimicrobial resistance
  • Prudent use of antimicrobial agents in human medicine
  • A European One Health Action Plan against Antimicrobial Resistance
  • Antimicrobial resistance — EU action
•  Communicable diseases
  • European Centre for Disease Prevention and Control
•  Vaccination
  • Seasonal influenza vaccination
  • The role of vaccination in the EU’s healthcare system
•  Major and chronic diseases
  • Alzheimer's disease and other dementias: EU initiatives
  • Promoting cancer screening in the EU
•  Rare diseases
  • Rare diseases — improving care and quality of life

F. Endrocrine disruptors

• Safe insect repellents, disinfectants and other industrial chemicals (biocides) in the EU

G. Health in the society

​
​Health and safety at work

• Advisory Committee on Safety and Health at Work (ACSH)
• Health and safety at work — general rules
• Health and safety of workers: conditions applicable to the workplace
• Protection of workers from exposure to biological agents
• Exposure to chemical agents
• Exposure to carcinogens and mutagens
• Exposure to asbestos: worker protection
• Exposure to artificial optical radiation
• Health and safety of workers in the extractive industries
• Health and safety at work: exposure to noise
• Fishing vessels — health and safety of workers on board
• Equal treatment of temporary agency workers
• Workplace health and safety for temporary workers
• Minimum health and safety standards while using work equipment
• Limiting the exposure of workers to risks from electromagnetic fields (from July 2016)
• Use of personal protective equipment
• Temporary and mobile work sites
• Workers’ health and safety in the mineral-extracting industries
• Protecting pregnant workers and new mothers
• Safety at work - manual handling of loads
• Preventing and reducing chemically induced illnesses and injuries at work
• Provision of health and safety signs at work
• Protection of young people at work​

H. Promoting good health

​

•  Nutrition and physical activity
  • Nutrition, overweight and obesity — EU strategy
  • Promoting healthy diet and physical activity across Europe
  • Promoting health-enhancing physical activity for all
  • Tackling the epidemic of childhood obesity
•  Alcohol
  • EU alcohol strategy
•  Tobacco
  • Preventing smoking
  • Protection from exposure to tobacco smoke
  • Tighter EU rules on tobacco
  • Tobacco advertising and sponsorship

I. Pharmaceuticals and medical devices

•  Medicines for human use
  • ​Safe medicines for Europeans — European Medicines Agency
  • Export of generic medicines to developing countries: compulsory licences
  • European Pharmacopoeia - EUR-Lex
  • High safety standards and streamlined procedures for EU clinical trials
  • Ingredients used in medicines – guidance for importers and distributors
  • EU rules on the authorisation, import and production of medicines for humans
  • EU rules for new medical products based on genes and cells
  • Ensuring the safety and performance of medical devices
  • Ensuring the safety and performance of in vitro diagnostic medical devices
  • Clinical Trials
  • Medicines for rare diseases - orphan drugs
  • Medicines and investigational medicines for human use — safe production
  • Medicinal products for paediatric use
  • Transparency of decisions regulating the prices and the reimbursement of medicinal products in EU countries
  • Supplementary protection certificates for medicines and plant protection products

​

•  Medicines for veterinary use
  • Authorisation, import and manufacture of veterinary medicines
  • Veterinary medicines — good manufacturing practice
  • Preparation and marketing of medicated feedingstuffs for animals
  • Residues of veterinary medicinal products in foodstuffs of animal origin
  • EU rules on the authorisation, import and production of veterinary medicines

​